MAPKs can positively regulate the production of inflammatory mediators such as tumor necrosis factor, interleukin-1β, and IL-6, and their impact in T cell development and activation have also been well reported, implicating MAPKs can play a role in the pathogenesis of autoimmune disease (38, 39). The gene discussed is IL6; the disease is autoimmune disease.